Abstract
Reference treatment of advanced prostate cancer (PCa) relies on pharmacological or surgical androgen deprivation therapy. However, it is only temporarily efficient as tumor cells inevitably adapt to the low testosterone environment and become hormone-refractory (HRPCa). We observed that androgen removal in HRPCa-derived LNCaP cells causes different alterations in their Ca(2+) homeostasis among which a reduction of ER Ca(2+) content. We show that the decrease in [Ca(2+)]ER is due to a modest overexpression of type 1 IP3R and a threefold increased phosphorylation of IP3R1 on Ser-1716, a protein kinase A (PKA) consensus site, both implicated in ER Ca(2+) leak. Accordingly, ER Ca(2+) content was restored by siRNA-mediated down-regulation of IP3R1 or by inhibition of its phosphorylation by competition with a permeant TAT-peptide containing the Ser-1716 consensus phosphorylation sequence or by treatment with the PKA inhibitor H89. Moreover, inhibition of the IP3R1 phosphorylation by both methods sensitized the LNCaP cells to androgen deprivation-induced apoptosis. In addition, SERCA2b overexpression precluded the effect of androgen deprivation on ER Ca(2+) store content and reduced resistance to androgen deprivation. Taken together, ...Continue Reading
References
Jan 1, 1988·The Prostate·J ConnorR Buttyan
Jan 25, 2003·Cell Calcium·C CamelloA V Tepikin
Oct 1, 2003·The Prostate·Adrie van BokhovenM Scott Lucia
Dec 20, 2003·Cell Death and Differentiation·K VanoverbergheN Prevarskaya
May 13, 2004·The Journal of Biological Chemistry·Fabien Vanden AbeeleNatalia Prevarskaya
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Nov 19, 2004·Cancer Research·Lei Zhang, Gregory John Barritt
Dec 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Scott A OakesStanley J Korsmeyer
Sep 5, 2006·Cellular Signalling·Anne-Katrine KvisselKristin Austlid Taskén
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dominik R BertholdIan F Tannock
Oct 16, 2008·Anti-cancer Agents in Medicinal Chemistry·A Bergner, R M Huber
Oct 29, 2008·Oncogene·P PintonR Rizzuto
Jan 10, 2009·Biochimica Et Biophysica Acta·Veerle VanderheydenJan B Parys
Apr 25, 2009·The International Journal of Biochemistry & Cell Biology·Carlotta GiorgiPaolo Pinton
Sep 4, 2010·Cellular Signalling·Dennis Merkle, Ralf Hoffmann
Jun 2, 2011·Cell Calcium·Clark W Distelhorst, Martin D Bootman
Nov 16, 2011·Autophagy·Jean-Paul DecuypereGeert Bultynck
Sep 12, 2012·Autophagy·Daniel J KlionskyBrian Zuckerbraun
Dec 13, 2012·Biochimica Et Biophysica Acta·Haidar Akl, Geert Bultynck
Mar 28, 2013·The Prostate·Benoît BoutinPhilippe Gailly
Jul 11, 2013·Science Signaling·Samuel BandaraTobias Meyer
Jan 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ming-Jin ChangClark W Distelhorst
Citations
Mar 26, 2016·Chinese Journal of Cancer·Jing WenKang-Qing Xu
May 10, 2016·Cell Calcium·Rita M L La RovereJan B Parys
Aug 12, 2016·Physiological Reviews·Michael J Berridge
Oct 28, 2019·Molecular Oncology·Alice H L BongGregory R Monteith
Nov 16, 2019·Annual Review of Physiology·Kozo Hamada, Katsuhiko Mikoshiba
Jan 28, 2017·Disease Markers·Xiaoyu ZhouJianan Huang
Mar 20, 2019·Cancers·Philippe KischelHalima Ouadid-Ahidouch
Aug 9, 2019·Cell Calcium·Cristina PierroH Llewelyn Roderick
Apr 3, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Fernanda O LemosJan B Parys
Dec 22, 2020·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Perla Pérez-TreviñoNoemí García
Jul 12, 2018·Journal of Medicinal Chemistry·Tengfei BianChengguo Xing